AMENDMENT TO CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • December 21st, 2018 • Endocyte Inc • Pharmaceutical preparations • Delaware
This Amendment to Change in Control and Severance Agreement (the “Amendment”) is made and entered into by and between Endocyte, Inc., a Delaware corporation (the “Company”), and (“Employee”), effective , 2018, to amend the Change in Control and Severance Agreement (“Agreement”) made and entered into effective as of , 20 , by and between the Company and Employee. Capitalized terms used but not defined herein shall have the meanings set forth in the Agreement.
